CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+22.53%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$295M
AUM Growth
+$295M
(+19%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| 1 |
NVIDIA
NVDA
|
$7.81M |
| 2 |
PayPal
PYPL
|
$4.77M |
| 3 |
STAAR Surgical
STAA
|
$3.64M |
| 4 |
Chipotle Mexican Grill
CMG
|
$3.46M |
| 5 |
Microsoft
MSFT
|
$3.33M |
Top Sells
| 1 |
iQIYI
IQ
|
$7.64M |
| 2 |
Pinduoduo
PDD
|
$6.59M |
| 3 |
ON Semiconductor
ON
|
$4.45M |
| 4 |
Apple
AAPL
|
$3.07M |
| 5 |
Rambus
RMBS
|
$2.77M |
Sector Composition
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Edgewise Therapeutics
EWTX
$1.55B
| $5.72K | ﹤0.01% |
857
+215
| +33% | +$1.43K |
|
352
Nurix Therapeutics
NRIX
$733M
| $5.69K | ﹤0.01% |
641
+162
| +34% | +$1.44K |
|
353
SIGA Technologies
SIGA
$625M
| $5.69K | ﹤0.01% |
989
+247
| +33% | +$1.42K |
|
354
Erasca
ERAS
$471M
| $5.62K | ﹤0.01% |
1,867
+624
| +50% | +$1.88K |
|
355
Repare Therapeutics
RPTX
$70M
| $5.61K | ﹤0.01% |
570
+144
| +34% | +$1.42K |
|
356
Scholar Rock
SRRK
$3.21B
| $5.6K | ﹤0.01% |
700
+175
| +33% | +$1.4K |
|
357
Ocular Therapeutix
OCUL
$2.18B
| $5.5K | ﹤0.01% |
1,043
+261
| +33% | +$1.38K |
|
358
Cullinan Oncology
CGEM
$460M
| $5.45K | ﹤0.01% |
533
+68
| +15% | +$696 |
|
|
IGMS
359
DELISTED
IGM Biosciences
IGMS
| $5.43K | ﹤0.01% |
395
+99
| +33% | +$1.36K |
|
|
TSVT
360
DELISTED
2seventy bio
TSVT
| $5.23K | ﹤0.01% |
513
+127
| +33% | +$1.3K |
|
361
Vanda Pharmaceuticals
VNDA
$290M
| $5.22K | ﹤0.01% |
769
+194
| +34% | +$1.32K |
|
362
Zscaler
ZS
$42.6B
| $5.14K | ﹤0.01% |
+44
| New | +$5.14K |
|
|
ALLK
363
DELISTED
Allakos
ALLK
| $5.14K | ﹤0.01% |
1,154
+289
| +33% | +$1.29K |
|
364
Monte Rosa Therapeutics
GLUE
$309M
| $5.11K | ﹤0.01% |
656
+164
| +33% | +$1.28K |
|
365
Kiniksa Pharmaceuticals
KNSA
$2.55B
| $5.04K | ﹤0.01% |
468
+117
| +33% | +$1.26K |
|
|
EGRX
366
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.02K | ﹤0.01% |
177
+45
| +34% | +$1.28K |
|
|
KLRS
367
Kalaris Therapeutics, Inc. Common Stock
KLRS
$73.3M
| $4.99K | ﹤0.01% |
1,266
+319
| +34% | +$1.26K |
|
|
ALPN
368
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $4.81K | ﹤0.01% |
623
+156
| +33% | +$1.2K |
|
369
Tango Therapeutics
TNGX
$751M
| $4.72K | ﹤0.01% |
1,195
+299
| +33% | +$1.18K |
|
370
Nautilus Biotechnolgy
NAUT
$86.3M
| $4.69K | ﹤0.01% |
1,692
+425
| +34% | +$1.18K |
|
371
SiriusXM
SIRI
$7.83B
| $4.67K | ﹤0.01% |
+1,177
| New | +$4.67K |
|
|
MRNS
372
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $4.64K | ﹤0.01% |
672
+187
| +39% | +$1.29K |
|
373
Tarsus Pharmaceuticals
TARS
$2.51B
| $4.55K | ﹤0.01% |
362
+91
| +34% | +$1.14K |
|
|
NGM
374
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4.54K | ﹤0.01% |
1,112
+282
| +34% | +$1.15K |
|
|
OMGA
375
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $4.5K | ﹤0.01% |
746
+258
| +53% | +$1.56K |
|